Back in November, changes were announced to diagnostic pathway for adult soft tissue sarcoma referrals in London. Services will be divided into ‘hubs’ (tertiary services providing treatment and clinical oversight) and ‘spokes’ (services delivering local diagnostics, from further imaging to pathology).

The Hubs are the Royal Marsden Hospital (RMH) and the London Sarcoma Service, which is a joint service between the Royal National Orthopaedic Hospital (RNOH) and University College London Hospitals (UCLH).

In west London, Spokes are currently located at Chelsea and Westminster NHS Foundation Trust (either the Chelsea or West Middlesex site), Croydon Health Services and Kingston Hospital.

In north central London, RNOH will act as a spoke for NCL with Wood Green CDC providing the diagnostic tests.

In east London, a Spoke will be established at Mile End Hospital.

More information about the changes to soft tissue sarcoma services.